| Cat.No.: | BSM-0171 |
| Product Name: | Mivebresib |
| CAS No.: | 1445993-26-9 |
| Figure: |
|
| Synonyms: | N-(4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide; ABBV-075 |
| Description: | Mivebresib is a potent BET inhibitor with potential antineoplastic activity. It disrupts critical transcription programs that drive prostate cancer growth to induce potent anti-tumor activity in vitro and in vivo. |
| Appearance: | Crystalline solid |
| Molecular Weight: | 459.47 |
| Purity: | ≥98% by HPLC |
| Storage: | -20°C |
| Targets: | BET |
| Molecular Formula: | C₂₂H₁₉F₂N₃O₄S |
| MDL Number: | MFCD03453554 |
| Solubility: | DMSO |
| Shipping Conditions: | Gel Pack |
| Warning: | For Research Use Only! Not For Use in Humans. |
USA
Enter your email here to subscribe.
Easy access to products and services you need from our library via powerful searching tools
